Scilex Holding Co (SCLX) dividend history

SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$1.56−0.06 (-3.70%)

Close on Nov 12, 2026Market cap $13.25MP/E –Yield –

Dividends

No dividend per share appears in Scilex's annual filings since fiscal 2019.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SCLX.

Revenue growth-28.5% · median 164.3%

Gross margin161.1% · median 89.3%

Operating margin-1136.4% · median -147.4%

Net margin-1469.8% · median -161.8%

Advertisement
300 × 250

See a number that looks wrong?